510(k) K232523 ยท CAF Nebulizer (Direct Patient Interface)
Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7%
| Applicant | Mankind Pharma Limited, New Delhi, IN |
| Decision | Substantially Equivalent, Apr 10, 2024 |
| Received | Aug 18, 2023 |
| Type | Traditional |
| FDA record | Open on fda.gov |
Recalls that name K232523
No recall in the FDA data names this 510(k).
Links come from the 510(k) numbers listed on each FDA recall record. We don't infer predicate chains.